On the one hand, increased serum IL-10 levels could facilitate development of cancer by suppressing expression of MHC class I and II antigens[7] and preventting tumor antigen presentation to CD8-cytotoxic T lymphocytes. The gene discussed is IL10; the disease is cancer.